<p>Weekly epidemiological record
Relevé épidémiologique hebdomadaire
24 OCTOBER 2014, 89th YEAR / 24 OCTOBRE 2014, 89e ANNÉE
No. 43, 2014, 89, 465–492
http://www.who.int/wer
2014, 89, 465-492
No. 43
Contents
465 Human papillomavirus vac-
cines: WHO position paper,
October 2014
Sommaire
465 Vaccins contre le papilloma-
virus humain: note de synthèse
de l’OMS, octobre 2014
465
WORLD HEALTH
ORGANIZATION
Geneva
ORGANISATION MONDIALE
DE LA SANTÉ
Genève
Annual subscription / Abonnement annuel
Sw. fr. / Fr. s. 346.–
10.2014
ISSN 0049-8114
Printed in Switzerland
Human papillomavirus
vaccines: WHO position
paper, October 2014
Introduction
In accordance with its mandate to provide
guidance to Member States on health pol-
icy matters, WHO issues a series of regu-
larly updated position papers on vaccines
and vaccine combinations against diseases
that have an international public health
impact. These papers are concerned pri-
marily with the use of vaccines in large-
scale immunization programmes. They
summarize essential background informa-
tion on their respective diseases and vac-
cines, and conclude with the current WHO
position concerning their use in the global
context.
The papers are reviewed by external ex-
perts and WHO staff, and reviewed and
endorsed by the WHO Strategic Advisory
Group of Experts (SAGE) on immuniza-
tion
(http://www.who.int/immunization/
sage/en/). The GRADE methodology is
used to systematically assess the quality
of available evidence. A description of the
process followed for the development of
vaccine position papers is available at:
http://www.who.int/immunization/posi-
tion_papers/position_paper_process.pdf.
The position papers are intended for use
mainly by national public health officials
and managers of immunization pro-
grammes. They may also be of interest to
international funding agencies, vaccine
advisory groups, vaccine manufacturers,
the medical community, scientific media
and the public.
This document replaces the first WHO
position paper on vaccines